These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11665507)

  • 1. The global burden and impact of chronic obstructive pulmonary disease worldwide.
    Gulsvik A
    Monaldi Arch Chest Dis; 2001 Jun; 56(3):261-4. PubMed ID: 11665507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic population model of disease progression in COPD.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; van Genugten ML; Buist AS; Wouters EF; Feenstra TL
    Eur Respir J; 2005 Aug; 26(2):223-33. PubMed ID: 16055869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hospitalization with chronic obstructive pulmonary disease-United States, 1990-2005.
    Brown DW; Croft JB; Greenlund KJ; Giles WH
    COPD; 2010 Feb; 7(1):59-62. PubMed ID: 20214464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease in women: exploring gender differences.
    Varkey AB
    Curr Opin Pulm Med; 2004 Mar; 10(2):98-103. PubMed ID: 15021178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden and impact of COPD in Asia and Africa.
    Chan-Yeung M; Aït-Khaled N; White N; Ip MS; Tan WC
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):2-14. PubMed ID: 14974740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.
    Mehta AJ; Miedinger D; Keidel D; Bettschart R; Bircher A; Bridevaux PO; Curjuric I; Kromhout H; Rochat T; Rothe T; Russi EW; Schikowski T; Schindler C; Schwartz J; Turk A; Vermeulen R; Probst-Hensch N; Künzli N;
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1292-300. PubMed ID: 22492989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COPD--chronic obstructive pulmonary disease and its implications for the human organism].
    Groneberg DA; Pleimes D; Golpon H; Welte T
    Versicherungsmedizin; 2006 Sep; 58(3):116-9. PubMed ID: 17002174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease in non-smokers.
    Salvi SS; Barnes PJ
    Lancet; 2009 Aug; 374(9691):733-43. PubMed ID: 19716966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management and costs of chronic pulmonary obstructive disease in France in 2011].
    Laurendeau C; Chouaid C; Roche N; Terrioux P; Gourmelen J; Detournay B
    Rev Mal Respir; 2015 Sep; 32(7):682-91. PubMed ID: 25613440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of chronic obstructive pulmonary disease].
    Scognamiglio A; Matteelli G; Pistelli F; Baldacci S; Carrozzi L; Viegi G
    Ann Ist Super Sanita; 2003; 39(4):467-84. PubMed ID: 15098569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
    Buist AS; Vollmer WM; McBurnie MA
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and global impact of chronic obstructive pulmonary disease.
    Mannino DM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of COPD: risk factors, prevalence, and future trends.
    Mannino DM; Buist AS
    Lancet; 2007 Sep; 370(9589):765-73. PubMed ID: 17765526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic costs of COPD in Sweden by disease severity--has it changed during a ten years period?
    Jansson SA; Backman H; Stenling A; Lindberg A; Rönmark E; Lundbäck B
    Respir Med; 2013 Dec; 107(12):1931-8. PubMed ID: 23910072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
    Slama K
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies.
    Ko FW; Hui DS; Lai CK
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):713-7. PubMed ID: 18544193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.